Video

Lemtrada's Benefits Can Help Multiple Sclerosis Patients Where Others Have Failed

Author(s):

In a longterm condition like multiple sclerosis finding the proper treatment option can often be a difficult task. A medication was recently approved to help patients who have struggled to find that help in the past.

In a longterm condition like multiple sclerosis finding the proper treatment option can often be a difficult task. A medication was recently approved to help patients who have struggled to find that help in the past.

Ann Bass, MD, from the Neurology Center of San Antonio discussed the advantages and potential risks of the medication at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis. Bass said the medication is given in two stages over the course of two years and many patients do not need a third dose after that making it an attractive option.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.